Vascular electrical stimulation therapy (VEST), a form of local electrical stimulation applied to the skin, can lower the duration of…
Articles by Joana Carvalho, PhD
The quality of life of people with sickle cell disease (SCD) and transfusion-dependent thalassemia (TDT) — two inherited blood disorders…
Bluebird Bio has paused two clinical trials of LentiGlobin, its gene therapy candidate for sickle cell disease (SCD),…
Oxbryta (voxelotor) can help ease, or fully heal, painful leg ulcers in people with sickle cell disease…
The U.S. Food and Drug Administration (FDA) has cleared the initiation of a Phase 1/2 trial investigating EDIT-301,…
The investigational gene editing therapy GPH101 will be the first potentially curative treatment for sickle cell disease (SCD)…
Emmaus Life Sciences has launched a program that will allow eligible sickle cell disease patients in the U.S. to…
Global Blood Therapeutics (GBT) has launched an early access program for voxelotor in Europe and other regions outside…
The European Commission has approved Novartis’ Adakveo (crizanlizumab) as a preventive treatment for recurrent vaso-occlusive crises…
Cyclerion Therapeutics has decided to suspend the development of olinciguat, its investigational oral therapy for sickle…